top of page
BioMed Reports
Artificial Intelligence in Healthcare, white paper
Author:
Alliancce for artificial Intelligence in Healthcare
This white paper is the product of a multidisciplinary team with collaboration across different areas and subject matter experts within AI in healthcare. Purpose of the Document is to introduce, define and clarify foundational topics, terms and concepts in AI with an emphasis on applications in healthcare, spanning the continuum from biomedical discovery, clinical development and patient care.
Global Artificial Intelligence (AI) in Drug Discovery Market – Industry Trends and Forecast to 2029
Author:
Data Bridge arket Research
Global Artificial Intelligence (AI) in Drug Discovery Market, By Application (Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation & Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug and Others), Technology (Machine Learning, Deep Learning, Natural Language Processing and Others), Drug Type (Small Molecule and Large Molecule), Offering (Software and Services), Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases and Others), End Use (Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies, Research Centers and Academic Institutes and Others) Industry Trends and Forecast to 2029.
Global Artificial Intelligence In Drug Discovery Market Size By Technology (Machine Learning, Deep Learning), By Application (Cardiovascular Diseases, Immuno-oncology), By End-User (Contract Research Organizations, Pharmaceutical & Biotechnology Companies), By Geographic Scope And Forecast
Author:
Verified Market Research
The Global Artificial Intelligence In Drug Discovery Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Intelligent drug discovery (Powered by AI)
Author:
Deloitte Centre for Health Solutions
The publication in the series on AI in Biopharma focuses on “Intelligent drug discovery” and showcases the impact that AI is making through a detailed review of 8 case studies. These case studies are from around the world and highlight the changing landscape of biopharma firms engaged in drug development; government and non-government interventions to drive AI-led discovery; and the growing importance of emerging markets in drug discovery.
bottom of page